New generation anti-psychotic medications are being used to treat aggressive behaviours in people with learning disabilities, whether or not individuals have a formal diagnosis of a mental health problem. This study set out to evaluate the effectiveness of two such new generation anti-psychotic medications, olanzapine and risperidone. The study looked at how effective these [read the full story…]
The prevalence of psychiatric disorders in people with learning disabilities is very difficult to ascertain with studies varying in their definitions and inclusion criteria. Estimates suggest that it may be as low as 3%, but despite this, antipsychotic medications comprise between 30–50% of all psychotropics prescribed for people with learning disabilities. This literature review set [read the full story…]
